Mirae Asset Global Investments
IGC icon

Mirae Asset Global Investments’s IGC Pharma IGC Stock Holding History

Mirae Asset Global Investments’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,377,257
Closed -$1.31M – 2418
2022
Q1 		$1.31M Sell
1,377,257
-284,136
-17% -$276K ﹤0.01% 1275
2021
Q4 		$1.62M Buy
1,661,393
+1,256,867
+311% +$1.69M ﹤0.01% 1164
2021
Q3 		$599K Buy
+404,526
New +$654K ﹤0.01% 1451

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Mirae Asset Global Investments's IGC Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of IGC Pharma (IGC) in Q2 2022, closing a stake of 1,377,257 shares — an estimated $1.31M sold.

Mirae Asset Global Investments first reported a position in IGC in Q3 2021 and held it in 3 quarters. The position peaked at $1.62M in Q4 2021. 29 funds tracked by Wall St. Rank hold IGC as of Q2 2022.

  • Mirae Asset Global Investments reported no remaining IGC Pharma position as of Q2 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,377,257 IGC Pharma shares in Q2 2022, an estimated $1.31M.
  • Mirae Asset Global Investments first reported a position in IGC Pharma in Q3 2021 and held it in 3 quarters.
  • Mirae Asset Global Investments's IGC Pharma position peaked at $1.62M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.